Today’s post is Symposia announcement #5! 🥳 More on our website: neuronusforum.pl/speakers/

Job Alert! Our school Monash Psychology is hiring 2 new T&R academics. A great opportunity to come and join a wonderful team! See the ads for details: nature.com/naturecareers/… nature.com/naturecareers/…

🚨 Donanemab - a new Alzheimer’s drug - has just been approved for use in the US. Donanemab remains under consideration by GB’s regulator - MHRAgovuk - with a decision expected in the coming months. We've answered your key questions about the drug here... 👇

Today, the FDA approved Kinsula (#donanemab) for the treatment of patients with #MCI and #Alzheimers, marking the first approval of an #AntiAmyloid drug with evidence that supports ceasing treatment once amyloid plaques are removed from the brain.

Our group of #ImageForensics experts Cheshire , Mu Yang, Ph.D., Matthew Schrag, and myself are currently posting the problems we found in these papers. We have now posted 118 of Dr. Masliah's paper onto PubSmear. Follow our progress here: pubpeer.com/search?q=%22El…

The NIH's research integrity scandal involving neuroscience chief and #Alzheimer’s/#Parkinson’s scientist Eliezer Masliah is of an extraordinary scale. It might be useful to follow one thread of the investigation involving the experimental drug prasinezumab from Prothena Corporation.

Older, compact plaques are more neurotoxic than diffuse ones, according to a new mouse study that timestamped amyloid deposits. #alzheimersdisease Göteborgs universitet / University of Gothenburg ow.ly/y3oK50TTvbY

Age and amyloidβ-dependent initiation of neurofibrillary tau tangles: an improved mouse model of Alzheimers disease without ... biorxiv.org/cgi/content/sh… #biorxiv_neursci

Happy to share that I have been promoted to Full Professor at Sahlgrenska Academy Göteborgs universitet / University of Gothenburg I would like to thank my talented students and team members, my colleagues, all collaborators and foremost my wonderful family who have all been accompanying on this exciting journey.

Leqembi recommended for treatment of early Alzheimer’s disease | European Medicines Agency (EMA). Good news and sensible from the EMA, congratulations on the reflection. ema.europa.eu/en/news/leqemb…

Happy to share our latest work published today in Nature Communications We leverage #ai enhanced microscopy guided #maldi MS_Imaging to delineate #amyloid plaque polymorphism in #Alzheimers Fantastic collaboration with Michael Schöll rdcu.be/ejcHj Sahlgrenska Academy UCL Queen Square Institute of Neurology

Dear immune/glia lovers of brain, gut and beyond… We’re looking for a lab tech/manager to join our team! Pls see details for application here ucl.ac.uk/work-at-ucl/se… UK Dementia Research Institute UCL - pls help circulate among networks who’d be of interest, thank you!

Delighted to share our latest study now published in Nature Portfolio Nat Comm. We leveraged stable isotope labelling (iSILK) and #MALDI #msimaging for annotating #amyloid plaque pathology based on plaque age in #Alzheimersdisease mice. MS_Imaging NIH nature.com/articles/s4146…

👏 Hanrieder’s lab combined cutting-edge techniques—mass spectrometry imaging, isotope labeling & GeoMx DSP—to reveal how Alzheimer’s plaques evolve and impact synapses over time. A big step for AD research! #Neuroscience #SpatialBiology Bruker Daltonics x.com/neurochem4/sta…